CBAI Invests in VIDAPLUS

February 14, 2011

Cord Blood America, Inc. (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has purchased a minority interest in Stem Cells VIDAPLUS, a Spanish-owned company which preserves umbilical cord stem cells at the Institute of Transfusion Medicine and Immunology of the Red Cross in Frankfurt, Germany.

“Headquartered in Madrid and founded in 2007, VIDAPLUS (www.vidapluscm.com) is one of the premier stem cell storage companies in Europe.  The Spanish economy is rebounding and we believe this investment both gives Cord Blood America an increased presence in Europe and diversifies our revenue stream,” said Matthew Schissler, Cord Blood America CEO and co-founder.

“The investment is organized in tranches that allows Cord Blood America to increase its stake in the Company over time including, eventually, taking a controlling interest,” Mr. Schissler said.  Cord Blood America previously announced it acquired 51 percent of stellacure GmbH in Germany, which also operates in conjunction with the German Red Cross.

{ 0 comments }


Cord Blood America Plans for Recapitalization

February 12, 2011

Cord Blood America, Inc. (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced yesterday that Matthew Schissler, CEO and co-founder, explains in detail the plans for the Company’s recapitalization in a ten-minute interview. The video and text of the speech is given below.

{ 0 comments }


Cancer Innovators To Bid On

November 29, 2010

According to pharmaceutical research firm IMS Health, U.S. sales of oncology drugs increased only 3.5 percent in the first nine months of 2010, compared to sales growth of 23 percent in 2006, 14 percent in 2007, and 9 percent in 2008 and 2009. The slowdown in sales growth is primarily being caused by price increases [...]

Read the full article →

Cord Blood America is Keen to Work with U.S. Health Insurance Companies

November 8, 2010

LAS VEGAS, Nov. 8, 2010  — Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that it is the first cord blood stem cell storage company to become an alliance partner [...]

Read the full article →

Analysis on Discovery Laboratories

June 18, 2010

1.) As of today, there are now 158.1M + 35.7M = 193.8M shares outstanding, with today adding 22.6% more dilution … its now basically doubled over the course of the past year!!! 2.) The Liquid Surfaxin is the Lead Program, and it is targeted to a $75M/yr U.S.-only market opportunity, which is currently served by [...]

Read the full article →

Top 50 US Stock as of 29 March

March 30, 2010

Below are the best-performing U.S. stocks year-to-date. Ranking  |  Company (Ticker)  |  Year-to-Date Performance Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) 717.6% Sterling Banks, Inc. (NASDAQ:STBK) 427.9% Zanett, Inc. (NASDAQ:ZANE) 422.6% Graham Packaging Company Inc (NYSE:GRM) 371.2% Star Scientific, Inc. (NASDAQ:CIGX) 298.6% Wabash National Corporation (NYSE:WNC) 282.5% Callon Petroleum Company (NYSE:CPE) 271.3% Semitool, Inc. (NASDAQ:SMTL) 260.3% Aspect Medical [...]

Read the full article →

Cyclacel Pharmaceuticals Target Price if Approved

March 27, 2010

Let’s look into brief profile of CYCC.  Cyclacel Pharmaceuticals, Inc has various drugs under develipment:  they are: Sapacitabine (CYC682):  An oral nucleoside analogue, which is in phase II studies for the treatment of hematological malignancies, , such as acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma, and lung cancer. Seliciclib (CYC202): A [...]

Read the full article →

Cord Blood America Grand Opening

January 26, 2010

On Januvary 22 nd Cord Blood America started another chapter by opening a Office and Lab atLas Vegas. Here is the video of the event. Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is [...]

Read the full article →

Sinovac Shines as Vaccine is Approved for more Population

November 17, 2009

BEIJING, Nov. 17 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA – News), a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company’s H1N1 vaccine. The population has been expanded to include people over 60 years old. The [...]

Read the full article →

BioElectronics Shines with Medical Breakthroughs

November 16, 2009

BioElectronics, the makers of inexpensive Drug Free, Anti-inflammatory Medical Devices and Patches. Recently chosen as “One of 9 Medical Breakthroughs That May Change Your Life.” Approved for sale in over 20 Countries including Canada, Italy, India and Korea. Producers of two product lines, Actipatch for retail sales and RecoveryRx for medical sales. BioElectronics Corp. (PINKSHEETS: [...]

Read the full article →

← Previous Entries